FDC346.40

FDC Limited

· Pharma & Health
₹ CrorePeersIOLCPMOREPENLABINNOVACAPORCHPHARMASENORESGUJTHEMRPGLIFESANOFIMcap ₹5,640 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
FDC
FY26
IOLCP
FY26
MOREPENLAB
FY26
INNOVACAP
FY26
Peer
Median
Valuation — at last close
P/E20.03×45.20×66.76×47.30×47.30× -58%
P/B2.27×3.46×5.07×6.11×5.07× -55%
EV/EBITDA14.79×23.37×51.49×28.68×28.68× -48%
Market Cap₹5,640 Cr₹6,223 Cr₹6,328 Cr₹6,667 Cr₹6,328 Cr -11%
Growth
Revenue CAGR 3Y6.77%1.51%8.40%4.96% +37%
Revenue CAGR 5Y10.24%8.73%8.73% +17%
Net Income CAGR 3Y13.23%-0.36%34.87%17.25% -23%
Revenue YoY (latest Q)2.97%37.08%34.07%33.94%34.07% -91%
Net Income YoY (latest Q)9.18%89.80%424.73%42.27%89.80% -90%
Profitability
EBITDA Margin15.94%11.60%6.96%14.90%11.60% +37%
Net Income Margin12.96%5.94%5.25%8.65%5.94% +118%
Return on Common Equity11.32%7.65%7.61%12.92%7.65% +48%
Return on Capital Employed11.23%9.95%6.17%14.73%9.95% +13%
Return on Assets9.64%5.32%4.90%7.67%5.32% +81%
Credit & Quality
Total Debt/Equity0.00×0.07×0.16×0.32×0.16× -100%
Interest Coverage57.54×12.97×5.43×11.70×11.70× +392%
Scale — latest FY
Revenue / Total Income₹2,171 Cr₹2,319 Cr₹1,806 Cr₹1,630 Cr₹1,806 Cr +20%
Net Income₹281 Cr₹138 Cr₹94.9 Cr₹141 Cr₹138 Cr +104%
Total Assets₹2,919 Cr₹2,587 Cr₹1,936 Cr₹1,837 Cr₹1,936 Cr +51%
EPS₹17.29₹4.69₹1.73₹24.63₹4.69 +269%
Book Value per Share₹152.64₹61.27₹22.76₹190.61₹61.27 +149%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.